Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable ...

Medicenna Therapeutics Corp.: Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, ...
PharmiWeb

Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunitie…

The A.I. Center of Excellence is planned to be based in Bengaluru and focus on large scale data-engineering, development and ...
PharmiWeb

Molecular Biology for the Non-molecular Biologist Training Course: Elevate Your Expertise in Pharmaceuticals Research, Development and Manufacturing (Apr 20th - Apr 21st, 2026 ...

The "Molecular Biology for the Non-molecular Biologist Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.Elevate your expertise in molecular ...